Moreover, subsequent ZnCl2 treatment prompted a remarkable elevation of ZIP14 expression, both at the transcript (Fig. 6A) and protein levels (Fig. 6B), in the fibrosis group, while it induced a reduction in expression within the sham group. The gene discussed is SLC39A14; the disease is fibrosis.